The quest to find a vaccine solution for Covid-19 is critically urgent, but experts in the field tell us we are at least 18 months aways from a viable product and human trials are a tricky process. Once we have the vaccine, there are many other barriers and hurdles before we see a working product in the general market.
We delve into the history of vaccines, explore the challenges and opportunities that face researchers, and the complexity of rollout once a solution is found. With the complexity of the vaccine solution more evident, what solutions should we be focusing on?
Get the latest headlines: https://www.telegraph.co.uk/
With thanks to:
Dr Amesh Adalja – Senior Scholar at the Johns Hopkins University Center for Health Security. Expert on emerging infectious disease, pandemic preparedness, and biosecurity.
Prof David Heyman – London School of Hygiene and Tropical Medicine. Headed the global response to the SARS outbreak at the WHO.
Prof Dirk Pfeiffer – Professor of Veterinary Epidemiology and Chair of One Health at City University of Hong Kong
Katherine Mason – Medical Anthropologist at Brown University
Paul Nuki – Global Health Security Editor at the Telegraph.
David Henig – Director at UK Trade Policy Project at European Centre for International Political Economy. Adviser on UK and global trade policy developments
Telegraph.co.uk and YouTube.com/TelegraphTV are websites of The Telegraph, the UK’s best-selling quality daily newspaper providing news and analysis on UK and world events, business, sport, lifestyle and culture.